Navigation Links
Chinese Distribution Contract Extended for an Additional 4 Years
Date:2/5/2010

FOUNTAIN HILLS, Ariz., Feb. 5 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ) announced today that they have extended the exclusive distribution agreement with Beijing Vision World Trading Co., Ltd. for an additional 4 years.

"I am very happy to sign this agreement," states G. Richard Smith, CEO of Sunridge International (www.sunridgeint.com). "We have worked closely with Beijing Vision World Trading Co., Ltd. (BV) over the last 3 1/2 years to complete the registration process for Pneumatic Trabeculoplasty, 'PNT' in China."

PNT is a two-minute, noninvasive, cost effective, alternative treatment for glaucoma and ocular hypertension, which was developed and patented by Ophthalmic International (www.oi-pnt.com), Sunridge Internationals wholly owned subsidiary.

"The registration process for a medical device and treatment is very strict in China.  It is a very long, expensive and tedious procedure," states Mr. Smith.  BV has worked tirelessly over the last 3 1/2 years at a tremendous financial cost to its company to compete this process.  They have performed several successful clinical trials at both private and state military hospitals as part of this effort.  With approval expected in the very near future, BV is now concentrating on its marketing efforts.  They have ordered and received delivery on 5 units with a substantial number of disposable rings, to be placed in 5 major hospitals in Beijing.  These hospitals will be used as models for the rest of the country.  They are currently negotiating with a number of companies to act as sub distributors to expand distribution throughout all of China.  They are attending different levels of Academy Conferences and Exhibitions as part of their "PNT" awareness program.  Doctors and distributor personal are being trained.  BV is doing everything possible to ensure the successful marketing of PNT in China.

Mr. Smith goes on to say, "that this is a significant event for OI.  China is a major market for us, with millions of Glaucoma patients.  The fact that a 'PNT' treatment lasts 3-4 months as a rule, with little or no side effects, makes it a very viable treatment for not only for the people of China, but for people everywhere.  We expect that this will prove to be a very profitable market for OI."

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission.

CONTACT:  Jeff Smith of Sunridge International, +1-480-837-6165, info@sunridgeint.com

SOURCE Sunridge International

RELATED LINKS
http://www.sunridgeint.com/
http://www.oi-pnt.com/

'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tainted Chinese Food Ingredients First Discovered in 2005
2. Chinese SFDA Grants Immtech Fast Track Status
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
5. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
6. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. Reportlinker Adds Chinese Markets for Respiratory Drugs
9. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
10. Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory
11. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)...  The U.S. Food and Drug Administration today granted ... adults and pediatric patients 12 years and older with ... not received prior chemotherapy. This is the first FDA-approved ... skin cancer. "While skin cancer is one ... form called Merkel cell cancer have not had an ...
(Date:3/23/2017)... British Columbia , March 23, 2017  Sophiris ... or "Sophiris"), a clinical late-stage biopharmaceutical company developing topsalysin ... that data from its successful Phase 2a study of ... for localized prostate cancer, will be presented as a ... Annual European Association of Urology in ...
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... ... therapy devices market to grow at a CAGR of 10.16% during ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... ... The physicians of KSF Orthopaedic Center PA are proud to announce the opening ... at 2255 E. Mossy Oaks Rd., Suite 440, Spring, Texas 77389 inside the new ... in the north Houston area (The Woodlands, Conroe, Magnolia, Kingwood, Humble) with an even ...
(Date:3/23/2017)... ... March 23, 2017 , ... PAINWeekEnd ... at 10 North Broadway Avenue, will be an educational and exciting program providing ... in the management of chronic pain. , Oklahoma is in a healthcare crisis. ...
(Date:3/23/2017)... ... ... of adults are unaware of the dangers that infectious bacteria play in mouth disease, while ... a day that dentists recommend. The ramifications of improper oral upkeep go far beyond bad ... 164 million hours of work each year due to dental issues. That is why Mediaplanet ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, ... mobile app and centralized benefits dashboard solving one of the top frustrations in ... locations. For the first time, employees can access up-to-date information and account balances ...
(Date:3/23/2017)... Malvern, PA (PRWEB) , ... March 23, 2017 ... ... a comprehensive educational training program owned and organized by HMP Communications Holdings, LLC, ... training program for physicians within its nationwide network of wound centers interested in ...
Breaking Medicine News(10 mins):